Ollin Biosciences, Inc. (Ollin), a clinical-stage biotech advancing best-in-disease therapies for vision-threatening diseases, today announced upcoming oral presentations featuring results from its ...

The age-related macular degeneration clinical trial analysis report delivers important insights into ongoing research of 100+ pipeline age-related macular degeneration drugs, clinical strategies, ...

A typical early symptom of age-related macular degeneration (AMD) is difficulty performing tasks under low-light conditions and in low-contrast surroundings. Patients may experience gradually ...

Weaker handgrip strength is linked to higher AMD incidence, with a stronger association observed in women compared to men. The study used UK Biobank data, excluding participants under 50 or with ...

Director Francesco Calabrò of the Ophthalmology Unit at Azienda Ospedaliera dei Colli, together with his team nurses Angela ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression of age-related macular degeneration, a leading cause of blindness in ...

Researchers have identified distinct biological features linked to a high risk of developing a severe form of age-related macular degeneration (AMD). Their findings, published in Genome Medicine, ...

Neovascular age-related macular degeneration (nAMD) is a progressive eye disease characterized by choroidal neovascularization and subretinal hemorrhage and exudation, leading to vision impairment.

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

Age-related macular degeneration (AMD), which affects about 200 million people worldwide and can result in legal blindness, impairs an area of the eye (retina) used for reading, driving and many other ...